Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / United States

Pfizer To Acquire FoldRx Pharmaceuticals

September 2010 | Industry Trend Analysis

BMI View: Pfizer is to expand into a promising but risky field of research and development (R&D), following its acquisition of FoldRx Pharmaceuticals. BMI believes that with the successful development of medicines to treat age-related chronic diseases associated with protein misfolding, Pfizer could enjoy considerable returns on its R&D investments. BMI expects the demand for treatments for such chronic diseases to increase considerably, due to the forecast growth of the world's ageing population over the next 50

To read the full article, please choose one of the following options:

Subcribers please log in

Related Insight Articles
Merck & Co Names New CEO

Industry / United States BMI View: The share price of Merck & Co will continue trading sideways until a positive catalyst is introduced. This stimulus is likely to be an enhanced strategy for the high-growth emerging markets...
December 2010
Potential Replacements For Warfarin

Industry / United States BMI View: Stroke prevention is a major therapeutic area in which drugmakers are looking to launch the next blockbuster. The size of the market and the risks associated with the standard warfarin therapy...
December 2010
Telemedicine Demand Exists, But Does It Work?

Industry / United States BMI Core View: Demand for products to aid non-institutional chronic disease management and improve independence among elderly patients will increase. The expected growth of the world's ageing population...
December 2010
Government Offers Innovation Grants To Expand High-Value Domestic Industries

Industry / United States BMI View: Uruguay's global competitiveness will benefit immensely from the current government's efforts to diversify and promote industrial sectors positioned in the upper part of the added value chain....
November 2010
GSK Divests Its Penicillin Manufacturing Site

Industry / United States BMI Core View: The generic drug industry will stratify into the following sub-sectors: unbranded/commodity generics; branded generics; value-added generics; and hard-to-manufacture generics. Branded generics...
November 2010


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2012 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS